ANI Pharmaceuticals Inc ANIP

Healthcare

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel, as well as its generics business with enhanced research and development capabilities. Its three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, and one is located in East Windsor, New Jersey, are together capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products. The Company has a commercial portfolio of approximately 118 products with a variety of indications and a robust portfolio of pipeline products.

NDAQ:ANIP - Post by User

ANI Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by whytestockson Sep 18, 2024 11:31am

23 Views

Post# 36229070

Outperform Recommendation Issued On ANIP By Raymond James

JUST IN: $ANIP Outperform Recommendation Issued On ANIP By Raymond James2024-09-18 10:30:03 ET Raymond James analyst issues OUTPERFORM recommendation for ANIP on September 18, 2024 09:14AM ET. The previous analyst recommendation was Outperform. ANIP was trading at $61.23 at issue of the analyst recommendation. The overall analyst consensus :...ANIP - Outperform Recommendation Issued On ANIP By Raymond James

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China